Catalyst Wire Dossier Catalyst Wire Dossier

RADIESSE (+) Lidocaine

calcium hydroxylapatite filler with lidocaine · Merz North America, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RADIESSE (+) Lidocaine, covering 2021-06-18 to 2021-06-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face [NA]

See pricing